These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

696 related items for PubMed ID: 30499317

  • 1. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
    Medellin MR, Fujiwara T, Tillman RM, Jeys LM, Gregory J, Stevenson JD, Parry M, Abudu A.
    Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
    [Abstract] [Full Text] [Related]

  • 2. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D, Zhang J, Li Y, Xia J, Yang Y, Ren M, Liao Y, Yu S, Li X, Shen Y, Zhang Y, Yang Z.
    World J Surg Oncol; 2016 Apr 19; 14():114. PubMed ID: 27094617
    [Abstract] [Full Text] [Related]

  • 3. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
    Abuhejleh H, Wunder JS, Ferguson PC, Isler MH, Mottard S, Werier JA, Griffin AM, Turcotte RE.
    Eur J Orthop Surg Traumatol; 2020 Jan 19; 30(1):11-17. PubMed ID: 31297594
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does pathological fracture affect the rate of local recurrence in patients with a giant cell tumour of bone?: a meta-analysis.
    Salunke AA, Chen Y, Chen X, Tan JH, Singh G, Tai BC, Khin LW, Puhaindran ME.
    Bone Joint J; 2015 Nov 19; 97-B(11):1566-71. PubMed ID: 26530662
    [Abstract] [Full Text] [Related]

  • 7. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
    Li X, Guo W, Yang Y, Wei R, DU ZY.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct 18; 45(5):745-51. PubMed ID: 24136271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Giant cell tumour of bone.
    Aoude A, Nikomarov D, Perera JR, Ibe IK, Griffin AM, Tsoi KM, Ferguson PC, Wunder JS.
    Bone Joint J; 2023 May 01; 105-B(5):559-567. PubMed ID: 37121582
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Outcome of re-operation for local recurrence following pre-operative denosumab administration and curettage for giant cell tumour of bone with difficult joint preservation.
    Tsukamoto S, Hindiskere S, Honoki K, Mavrogenis AF, Tanaka Y, Chinder PS, Donati DM, Errani C.
    Int Orthop; 2023 Jan 01; 47(1):265-273. PubMed ID: 36282294
    [Abstract] [Full Text] [Related]

  • 15. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
    Xing R, Yang J, Kong Q, Tu C, Zhou Y, Duan H.
    Acta Orthop Belg; 2013 Dec 01; 79(6):731-7. PubMed ID: 24563982
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Giant cell tumor with pathologic fracture: should we curette or resect?
    van der Heijden L, Dijkstra PD, Campanacci DA, Gibbons CL, van de Sande MA.
    Clin Orthop Relat Res; 2013 Mar 01; 471(3):820-9. PubMed ID: 22926445
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.